It is noteworthy that STAT3 repression of MHC-I is dominant in lung cancer cells, although STAT1, another target of PDLIM2 for degradation, is known to induce MHC-I expression after activation by IFNγ12,52. Here, STAT1 is linked to lung carcinoma.